Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view

被引:28
作者
Simon Junior, Hany [1 ,2 ]
Shimoda Sakano, Tania Miyuki [1 ,2 ]
Rodrigues, Regina Maria [1 ,2 ]
Eisencraft, Adriana Pasmanik [1 ,2 ]
Lemos de Carvalho, Vitor Emanoel [1 ,2 ]
Schvartsman, Claudio [1 ,2 ]
Afonso da Costa Reis, Amelia Gorete [1 ,2 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Crianca,Dept Emergencia, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Crianca, Sao Paulo, SP, Brazil
关键词
Coronavirus disease (COVID-19); Emergency department; Inflammatory syndrome; Kawasaki disease; Pediatrics; SARS-CoV-2; KAWASAKI-DISEASE; CYTOKINE STORM; CORONAVIRUS; ACTIVATION; MANAGEMENT; STATEMENT; DIAGNOSIS; CHILDREN; THERAPY;
D O I
10.1016/j.jped.2020.08.004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Multisystem inflammatory syndrome in children (MIS -C) associated with coronavirus disease (COVID-19) is a rare and challenging diagnosis requiring early treatment. The diagnostic criteria involve clinical, laboratory, and complementary tests. This review aims to draw pediatrician attention to this diagnosis, suggesting early treatment strategies, and proposing a pediatric emergency care flowchart. Sources: The PubMed/MEDLINE/WHO COVID-19 databases were reviewed for original and review articles, systematic reviews, meta -analyses, case series, and recommendations from medical societies and health organizations published through July 3, 2020. The reference lists of the selected articles were manually searched to identify any additional articles. Summary of the findings: COVID-19 infection is less severe in children than in adults, but can present as MIS -C, even in patients without comorbidities. There is evidence of an exacerbated inflammatory response with potential systemic injury, and it may present with aspects similar to those of Kawasaki disease, toxic shock syndrome, and macrophage activation syndrome. MIS -C can develop weeks after COVID-19 infection, suggesting an immunomediated cause. The mostfrequent clinical manifestations include fever, gastrointestinal symptoms, rash, mucous membrane changes, and cardiac dysfunction. Elevated inflammatory markers, lymphopenia, and coagulopathy are common laboratory findings. Supportive treatment and early immunomodulation can control the intense inflammatory response and reduce complications and mortality. Conclusions: MIS -C associated with COVID-19 is serious, rare, and potentially fatal. The emergency department pediatrician must recognize and treat it early using immunomodulatory strategies to reduce systemic injury. Further studies are needed to identify the disease pathogenesis and establish the most appropriate treatment. (C) 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
引用
收藏
页码:140 / 159
页数:20
相关论文
共 78 条
  • [1] Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children
    Abdel-Mannan, Omar
    Eyre, Michael
    Lobel, Ulrike
    Bamford, Alasdair
    Eltze, Christin
    Hameed, Biju
    Hemingway, Cheryl
    Hacohen, Yael
    [J]. JAMA NEUROLOGY, 2020, 77 (11) : 1440 - 1445
  • [2] Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
    Alijotas-Reig, Jaume
    Esteve-Valverde, Enrique
    Belizna, Cristina
    Selva-O'Callaghan, Albert
    Pardos-Gea, Josep
    Quintana, Angela
    Mekinian, Arsene
    Anunciacion-Llunell, Ariadna
    Miro-Mur, Francesc
    [J]. AUTOIMMUNITY REVIEWS, 2020, 19 (07)
  • [3] Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
    Alunno, Alessia
    Carubbi, Francesco
    Rodriguez-Carrio, Javier
    [J]. RMD OPEN, 2020, 6 (01):
  • [4] American College of Reumatology, 2020, CLIN GUID PED PAT MU
  • [5] Remdesivir for the Treatment of Covid-19-Final Report
    Beigel, John H.
    Tomashek, Kay M.
    Dodd, Lori E.
    Mehta, Aneesh K.
    Zingman, Barry S.
    Kalil, Andre C.
    Hohmann, Elizabeth
    Chu, Helen Y.
    Luetkemeyer, Annie
    Kline, Susan
    de Castilla, Diego Lopez
    Finberg, Robert W.
    Dierberg, Kerry
    Tapson, Victor
    Hsieh, Lanny
    Patterson, Thomas F.
    Paredes, Roger
    Sweeney, Daniel A.
    Short, William R.
    Touloumi, Giota
    Lye, David Chien
    Ohmagari, Norio
    Oh, Myoung-don
    Ruiz-Palacios, Guillermo M.
    Benfield, Thomas
    Faetkenheuer, Gerd
    Kortepeter, Mark G.
    Atmar, Robert L.
    Creech, C. Buddy
    Lundgren, Jens
    Babiker, Abdel G.
    Pett, Sarah
    Neaton, James D.
    Burgess, Timothy H.
    Bonnett, Tyler
    Green, Michelle
    Makowski, Mat
    Osinusi, Anu
    Nayak, Seema
    Lane, H. Clifford
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) : 1813 - 1826
  • [6] Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
    Belhadjer, Zahra
    Meot, Mathilde
    Bajolle, Fanny
    Khraiche, Diala
    Legendre, Antoine
    Abakka, Samya
    Auriau, Johanne
    Grimaud, Marion
    Oualha, Mehdi
    Beghetti, Maurice
    Wacker, Julie
    Ovaert, Caroline
    Hascoet, Sebastien
    Selegny, Maelle
    Malekzadeh-Milani, Sophie
    Maltret, Alice
    Bosser, Gilles
    Giroux, Nathan
    Bonnemains, Laurent
    Bordet, Jeanne
    Di Filippo, Sylvie
    Mauran, Pierre
    Falcon-Eicher, Sylvie
    Thambo, Jean-Benoit
    Lefort, Bruno
    Moceri, Pamela
    Houyel, Lucile
    Renolleau, Sylvain
    Bonnet, Damien
    [J]. CIRCULATION, 2020, 142 (05) : 429 - 436
  • [7] COVID-19 outbreak: less stethoscope, more ultrasound
    Buonsenso, Danilo
    Pata, Davide
    Chiaretti, Antonio
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (05) : E27 - E27
  • [8] The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
    Burns, Jane C.
    Franco, Alessandra
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (07) : 819 - 825
  • [9] Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies
    Cancio, Maria
    Ciccocioppo, Rachele
    Rocco, Patricia R. M.
    Levine, Bruce L.
    Bronte, Vincenzo
    Bollard, Catherine M.
    Weiss, Daniel
    Boelens, Jaap Jan
    Hanley, Patrick J.
    [J]. CYTOTHERAPY, 2020, 22 (09) : 474 - 481
  • [10] Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]